InvestorsHub Logo
Followers 466
Posts 26938
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 198

Wednesday, 01/25/2012 8:54:24 AM

Wednesday, January 25, 2012 8:54:24 AM

Post# of 240
Santarus(SNTS_) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists. This stock is trading up 7% at $4.09 in recent trading after hitting a 52-week high of $4.10 earlier in the day.

Today's Range: $3.78-$4.10

52-Week Range: $2.40-$3.84

Volume: 452,000

Three-Month Average Volume: 276,948

Santarus has a market cap of $246.53 million and an enterprise value of $183.79 million. The stock trades at a trailing price-to-earnings of 368.18 and a forward price-to-earnings of 21.32. Its estimated growth rate for this year is 131.8%, and for next year it's pegged at 171.4%.

From a technical standpoint, SNTS has triggered a big breakout today now that the stock has taken out some past overhead resistance at $3.70 with big volume. This stock now has a chance to fill a big gap down from back in 2010 that could take the stock back towards $5.67 to $5.82.

Look for SNTS to close near today's highs and remain above $3.70 to signal that long-biased trades are the best play from here.

http://www.thestreet.com/story/11373439/6/5-stocks-hitting-new-52-week-highs.html


surf's up......crikey